#United States #San Diego #Precision Oncology #Tempus #Soteria

SOTERIA Partners with Tempus to Transform Cancer Treatment for Military

In a groundbreaking initiative aimed at improving cancer treatment for the U.S. military and veterans, the SOTERIA Precision Medicine Foundation has announced a collaboration with Tempus, a leading technology company specializing in precision medicine. This partnership seeks to leverage advanced genomic sequencing technologies and data-driven insights to enhance care for those who have served in the armed forces.

Addressing a Critical Need

As cancer diagnoses in military personnel occur at increasingly younger ages and often at advanced stages, the need for personalized care has never been more pressing. The collaboration supports SOTERIA's Cancer Hunt™ initiative, which aims to deliver tailored oncology patient navigation. By harnessing Tempus' proprietary genomic profiling and AI-enabled diagnostics, this initiative will facilitate the identification of targeted therapies and clinical trial opportunities.

Julia Civardi, Founder and CEO of SOTERIA, emphasized the importance of equipping patients with the right tools and technology for effective treatment. She remarked, "Our mission is to ensure that patients have access to solutions that can guide them toward the most effective treatment options available. Collaborating with Tempus allows us to integrate cutting-edge genomic data into patient care, enabling both patients and healthcare providers to make more informed decisions."

Transformative Genomic Insights

Through this partnership, the two organizations aim to transform complex genomic data into actionable insights. Tempus is known for its sophisticated analytics capabilities, and through this initiative, their insights will be directly accessible to clinicians and patients alike, a crucial factor in making timely treatment decisions in the face of cancer. Ezra Cohen, M.D., the Chief Medical Officer of Oncology at Tempus, stated, "We are proud to support SOTERIA's mission and help enhance precision oncology for our nation's service members and veterans."

A New Era for Military Healthcare

The collaboration reflects a concerted effort to bridge the gap between innovative medical technologies and the unique healthcare needs of military family members. CAPT Rob Newson, a retired Navy SEAL and currently the Chief Community Officer at SOTERIA, noted the significant challenges that cancers present to military families. Expressing deep commitment to this initiative, he stated, "This partnership showcases the power of merging technological advances with dedicated service to support those who have served our nation."

To ensure that military members benefit from the full spectrum of care options, SOTERIA offers comprehensive molecular profiling and enhances its data integration efforts across its patient population. This step not only advances precision oncology research but also optimizes care pathways for military individuals diagnosed with cancer.

Join the Movement

As the fight against cancer continues, SOTERIA and Tempus urge military families and veterans to take advantage of this innovative partnership. Individuals interested in exploring the Cancer Hunt™ initiative or scheduling consultations with SOTERIA's nurse navigators can do so through the organization's dedicated online platform, ensuring that everyone gets the personalized care they deserve.

To learn more about SOTERIA's efforts in precision oncology, visit their website or contact their media relations team for more information. The merging of military service and medical innovation holds the promise of not only better outcomes but also a renewed hope for countless families across the nation.